Phase
Condition
Hormone Deficiencies
Treatment
Norethindrone Acetate-Ethinyl Estradiol
Clinical Study ID
Ages 18-65 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- AVD Group:
Adults 18-65 years old Arginine-vasopressin deficiency Stable pituitary hormone replacement
- Healthy Control Group Adults 16-65 years old
Exclusion Criteria for all participants:
History of pulmonary embolism, deep vein thrombosis, breast/endometrial cancer, stroke, transient ischemic attack, myocardial infarction, angina pectoris, or peripheral artery disease
Pregnancy or breastfeeding within last 8 weeks
Any significant illness or condition that the investigator determines could interfere with study participation, data collection, or safety
Study Design
Connect with a study center
Massachusetts General Hospital
Boston, Massachusetts 02114
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.